Natixis Advisors, L.P. Edwards Lifesciences Corp Transaction History
Natixis Advisors, L.P.
- $46 Billion
- Q2 2024
A detailed history of Natixis Advisors, L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 248,405 shares of EW stock, worth $16.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
248,405
Previous 222,367
11.71%
Holding current value
$16.3 Million
Previous $21.2 Million
7.98%
% of portfolio
0.05%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding EW
# of Institutions
1,417Shares Held
469MCall Options Held
2.44MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.51 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.34 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.7 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.33 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.11 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $40.5B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...